Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
DE Stocks

MDQK.HM MediNavi AG (HAM) jumps 200% to €7.50 04 Mar 2026: momentum may fade

March 4, 2026
5 min read
Share with:

MediNavi AG (MDQK.HM) spiked 200.00% to €7.50 on HAM during market hours on 04 Mar 2026, making it a high-volume mover despite thin trading. The MDQK.HM stock opened at €2.50, hit a day low of €2.50 and a day high of €7.50. Volume was 35 shares versus an average of 41, so price moves reflect low liquidity and momentum trades rather than broad market conviction. We break down drivers, technicals, valuation signals, and a Meyka AI forecast to help traders weigh risk and opportunity.

MDQK.HM stock: Intraday surge and what moved the price

The immediate driver was a sharp re-rating from €2.50 to €7.50, a €5.00 move equal to 200.00% on the day. Low float and limited free trading stock float amplified orders. The stock’s 50-day average is €2.50 and the 200-day average is €1.9976, showing recent baseline levels well below today’s print. Sector context: Healthcare performance is muted year-to-date, so this spike looks idiosyncratic and trade-driven rather than sector-led.

Sponsored

MDQK.HM stock: Technical and volume read

On technicals the Keltner middle sits at €7.50 and ATR is 5.00, indicating extreme intraday volatility. RSI and MACD readouts are effectively unavailable, reflecting short trading history at this level. Average volume is 41 and today’s volume was 35, so relative liquidity is low. Price averages (50-day €2.5024, 200-day €1.9976) show recent upward bias before today’s gap, but the move lacks confirming volume breadth.

Financial snapshot and valuation metrics for MDQK.HM stock

Public filings show limited reported operating figures: EPS and PE are not available. Enterprise value over EBITDA is 2.17, current ratio reads 41.50, and interest coverage is -1362.59, reflecting nonstandard accounting and low trading market cap. Year high is €7.50 and year low is €1.50. These metrics point to a small, thinly traded healthcare information services firm with weak operating history but strong book liquidity measures.

Meyka AI rates MDQK.HM with a score out of 100 and analyst take

Meyka AI rates MDQK.HM with a score out of 100: 62.57/100 (B, HOLD). This grade factors S&P 500 benchmark comparison, sector and industry comparisons, financial growth, key metrics, forecast inputs, analyst consensus and fundamental growth. The B grade reflects mixed signals: strong short-term price action but thin liquidity and incomplete earnings data. This grade is informational only and not investment advice.

MDQK.HM stock: Risks and catalysts to watch

Primary risks are liquidity, limited public financial disclosure, and potential wash trading in low-volume contexts. Catalysts that could validate the move include a corporate announcement, confirmed partnership, or renewed user growth at MediNavi AG. Watch intraday volume above 100 shares as a threshold for more reliable price discovery. Regulatory updates in German healthcare directories could also move valuation.

Trading strategy, realistic price targets and scenario planning

For short-term traders, use tight risk controls: stop-losses near intraday support. For position traders, consider staged exposure only after sustained volume above the 50-day average. We set realistic model-based targets: a conservative reversion target near €2.80 and a bullish 12-month target near €9.00. Use position sizing to limit capital at risk given the stock’s extreme intraday moves and low liquidity.

Final Thoughts

Key takeaways: MDQK.HM stock jumped 200.00% to €7.50 on HAM on 04 Mar 2026, driven by very low liquidity and short-term buying pressure. The company operates in Healthcare information services with limited public earnings, creating valuation uncertainty. Meyka AI’s forecast model projects a conservative six-month target at €2.80, implying a -62.67% move from €7.50, and a bullish 12-month target at €9.00, implying 20.00% upside. Forecasts are model-based projections and not guarantees. Traders should demand higher volume confirmation, monitor corporate news via MediNavi website, and read the company profile image and filings on the official profile source. Meyka AI, our AI-powered market analysis platform, flags MDQK.HM as high risk with mixed reward potential. Use strict risk limits and verify any news before trading.

FAQs

Why did MDQK.HM stock jump 200% today?

The 200% jump to €7.50 came on very low volume and tight float. Limited liquidity magnified orders. No public earnings release explains it, so the move looks trade-driven rather than fundamental.

What is the Meyka AI grade for MDQK.HM stock?

Meyka AI rates MDQK.HM at 62.57/100, grade B with a HOLD suggestion. The grade blends benchmark and sector comparison, financials, forecasts, and analyst signals.

What price targets should traders use for MDQK.HM stock?

Meyka AI’s forecast model projects a conservative target of €2.80 and a bullish target of €9.00. These are model projections and not guarantees; manage risk accordingly.

Is MDQK.HM stock liquid enough for large trades?

No. Average volume is 41 shares and today’s volume was 35. That low liquidity creates execution risk and wide spreads for large orders, so scale trades carefully.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)